Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 22, 2023 08:00 ET | Source: Alimera Sciences, Inc.

Alimera Announces Submission of Marketing Authorization Application in Switzerland for ILUVIEN®

ATLANTA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners...
January 09, 2023 08:00 ET | Source: Alimera Sciences, Inc.

Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officer

ATLANTA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners...